Form 4: Moderna Executive Stephen Hoge Reports Stock Transactions

Moderna's President, Stephen Hoge, executed stock transactions involving the vesting of restricted stock units and a sale to cover tax obligations.

Summary

• Stephen Hoge, President of Moderna, reported transactions involving the company's common stock.
• On December 2, 2024, 651 restricted stock units (RSUs) vested and converted into common stock.
• On December 3, 2024, 314 shares were sold at $43.2971 per share to cover tax withholding obligations related to the vesting of the RSUs.
• Following these transactions, Hoge directly owns 1,443,904 shares of common stock.
• Hoge also indirectly owns 4,116 shares through Valhalla, LLC and 151,933 shares through a trust.

Sentiment

Score: 5

Explanation: The document reflects routine stock transactions by an executive, which is neither positive nor negative for the company's overall outlook.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common practice for publicly traded companies.

Comparison to Industry Standards

• Executive stock transactions are a common occurrence in publicly traded companies, and the reporting of these transactions via SEC Form 4 is standard practice.
• The 'sell to cover' transaction for tax obligations is a typical mechanism used by companies to manage equity compensation.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are routine and related to executive compensation.

Key Dates

Keywords

Moderna, MRNA, Stephen Hoge, Stock Transactions, Restricted Stock Units, RSU, SEC Form 4, Insider Trading, Beneficial Ownership